Explore our highly refined chemical ingredients engineered for therapeutic, aesthetic, and industrial applications.
An authoritative analysis of Sodium Deoxycholate (CAS 302-95-4) demands, purity benchmarks, and industrial paradigms.
Sodium Deoxycholate (Na Deoxycholate) is a critical sodium salt of the bile acid deoxycholic acid. In the global pharmaceutical and chemical sectors, its performance as an ionic detergent has made it indispensable. Historically utilized for basic detergent functions in biochemical assays, modern biomedical advancements have catapulted Na Deoxycholate into a highly sought-after active pharmaceutical ingredient (API) and functional excipient. Its ability to effectively lyse cell membranes, solubilize membrane proteins, and promote localized fat dissolution underpins its rapid market growth.
The global commercial landscape for Na Deoxycholate is currently driven by two massive pillars: the biopharmaceutical manufacturing industry and the aesthetic medicine sector. In downstream bioprocessing, Na Deoxycholate is a standard tool for vaccine manufacturing, membrane protein isolation, and viral inactivation. Concurrently, the explosion of non-invasive body contouring treatments—specifically targeted submental fat reduction injectables—has generated unprecedented volume demands for ultra-high purity, endotoxin-controlled injectable-grade Sodium Deoxycholate. Procurement directors at multinational biotech firms are shifting from generic laboratory suppliers to dedicated OEM manufacturers who can guarantee compliance, strict impurity limits, and seamless supply chain security.
A key trend shaping global procurement is the demand for custom particle sizes, sterile processing, and absolute biological safety (BSE/TSE-free certification). Because deoxycholic acid is traditionally synthesized or extracted from animal bile, strict regulatory protocols apply to prevent bovine spongiform encephalopathy cross-contamination. Major buyers across North America, Europe, and Japan are demanding detailed documentation pathways, prompting manufacturers like Chenlv Herb to deploy strict trace-back systems and cleanroom refinement processes. These stringent E-E-A-T requirements differentiate leading OEM suppliers from regional commodity traders.
Utilized for downstream purification, membrane protein isolation, and as an active detergent in viral clearance protocols for vaccine production.
Serves as the key API in injectable formulations designed for localized fat cell lysis, demanding zero-endotoxin and pyrogen-free parameters.
Integral in formulating cell lysis buffers, RIA/ELISA kits, and molecular diagnostics assays due to its reliable surfactant properties.
A premier high-tech enterprise specializing in R&D, production, and sales of high-purity natural ingredients since 2012.
Established in 2012, Chengdu Chenlv Herb Co., Ltd. (Chenlv Herb) has grown into a world-class manufacturing authority for botanical extracts and natural pharmaceutical ingredients. Committed to providing highly active, pure, and premium raw materials, our solutions serve global pharmaceutical, nutraceutical, cosmetic, and diagnostic industries. Backed by state-of-the-art analytical equipment and rigorous quality control systems, our mission is to deliver reliable chemical ingredients that align perfectly with the evolving standards of international regulatory bodies.
How our automated facility guarantees consistent quality, regulatory compliance, and cost optimization.
In the chemical synthesis and extract industries, consistency is the hallmark of reliability. Chenlv Herb’s manufacturing plant incorporates Factory 4.0 principles, deploying closed-loop control systems, automated crystallization technologies, and online monitoring arrays to ensure batch-to-batch consistency. Our 2,711㎡ facility is designed to eliminate manual handling during crucial purification phases. For delicate products like Sodium Deoxycholate, this automation significantly lowers microbial and endotoxin risks, ensuring that every batch shipped matches the specifications established during pilot testing.
Moreover, global supply chain bottlenecks have highlighted the value of regional resilience. Our factory is situated near rich sourcing hubs for high-quality cholic acid intermediates, reducing raw material procurement latency. Combined with our agile production scheduling, we maintain a buffer inventory that helps stabilize pricing against raw material inflation. For global procurement officers, this operational model delivers two key benefits: a significant decrease in lead times and a reliable buffer against the price volatility that often plagues biochemical products.
Every step of the OEM manufacturing process is tracked via our digital Quality Management System (QMS). From raw cholic acid analysis, chemical conversion, recrystallization, to heavy metal filtration and final cleanroom packaging, each batch receives a comprehensive dossier. This deep documentation supports rapid regulatory submissions and satisfies the most demanding compliance checks from international health authorities.
By bypassing third-party chemical brokers and sourcing intermediates directly, we achieve a leaner, highly cost-effective manufacturing flow.
We deploy closed-loop solvent recovery units and biological waste treatment programs to minimize our ecological footprint and comply with modern ESG initiatives.
Our dynamic reactor configurations allow for quick shifts between commercial runs and custom OEM pilot batches, keeping us aligned with buyer timelines.
How our custom-manufactured Sodium Deoxycholate solves unique formulation challenges across four major sectors.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for the development of health care products due to their natural, green and safe characteristics.
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy the prominent position in the pharmaceutical industry due to their natural active ingredients and unique pharmacological effects.
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new solutions for skin care.
Plant extracts have shown great potential in improving animal health, enhancing production performance and optimizing culture benefits, and are gradually becoming a research hotspot and new favorite in the field of animal nutrition.
Chenlv Herb provides one-stop contract manufacturing services customized to your unique specifications.
01
We work with you to outline your targets, quantity requirements, and regulatory needs.
02
We provide a transparent cost and delivery projection based on your custom requirements.
03
We secure mutual targets with a comprehensive non-disclosure agreement and formal contract.
04
Our lab team develops custom samples matching your exact chemical profile for approval.
05
Following approval of the pilot sample, we initiate automated bulk production run.
06
We run physical and chemical quality assays, generating the final Certificate of Analysis.
07
Secure packaging and export-ready logistics ensure safe, timely delivery to your facility.
Our systems comply with global quality, safety, and operational standards.
To support global supply chains and simplify regulatory audits, Chengdu Chenlv Herb Co., Ltd. holds a comprehensive set of international certifications. Our quality management system and production facilities comply with ISO9001, ISO22000, HALAL, KOSHER, and FDA standards. We welcome third-party audits and provide complete batch documentation, including chromatograms (HPLC/GC), heavy metal tests, and microbiological verification files.
Catch up on our latest technological breakthroughs, trade shows, and analysis of market dynamics.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end, price fluctuations remain a focal point due to supply and demand dynamics.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery Show.
Chengdu Chenlv Herb sincerely invites you to attend the 92nd API conference to discuss new chapters in biotechnology, high-purity bile acid extraction processes, and our custom OEM chemical production capabilities.
Answers to key technical, regulatory, and logistical questions frequently asked by procurement directors.
Receive up-to-date pricing trends, regulatory analysis, and pharmaceutical ingredient market updates directly to your inbox. We reply to all procurement inquiries within 24 hours.
Request Quote & Technical DatasheetExplore our highly refined chemical ingredients engineered for therapeutic, aesthetic, and industrial applications.
